Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Next Generation Herpes Simplex Virus Vaccines".
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, United States. Electronic address: david_knipe@hms.harvard.edu.
David M
DM
Knipe
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Lawrence
L
Corey
Laboratory of Infectious Diseases, NIAID, Bethesda, MD, United States.
Jeffrey I
JI
Cohen
Division of Microbiology and Infectious Diseases, NIAID, Bethesda, MD, United States. Electronic address: CDeal@niaid.nih.gov.
Carolyn D
CD
Deal
D006561:Herpes Simplex / Q000517:prevention & control*; D022301:Herpes Simplex Virus Vaccines; D006801:Humans; D054579:National Institute of Allergy and Infectious Diseases (U.S.); D016032:Randomized Controlled Trials as Topic; D014481:United States; D014611:Vaccination / Q000639:trends; D014759:Viral Envelope Proteins / Q000276:immunology
D022301:Herpes Simplex Virus Vaccines; D014759:Viral Envelope Proteins; C039447:glycoprotein D, Human herpesvirus 1